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Background: Matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS) recently
became available for the identification of bacteria in routine diagnostic laboratories. It is rapid and cost-effective and
likely to replace phenotypic identification. This study was undertaken to compare two MALDI-TOF MS-based, Bruker
Microflex MS (BMS) and VITEK MS (VMS) systems, for identification (ID) of clinically significant bacterial isolates. Clinically
relevant broad diversity of bacterial isolates obtained during a 6-consecutive months of routine laboratory processing
of clinical specimens were subjected to ID by the BMS and VMS in parallel with Vitek 2, a conventional phenotypic
system (CPS). For the BMS, the isolates were tested in duplicates directly and after pretreatment. Identification was
provided with accompanying scores according to manufacturers’ instructions. With VMS, single deposits of the same sets
of isolates were tested in duplicates directly on MALDI-plate. Results were interpreted according to the manufacturer’s
protocols. Discrepant results were resolved by 16S rRNA gene amplification and sequencing.
Results: A total of 806 pathogens comprising 507 Gram-negative bacilli (GNB), 16 Gram-negative cocci (GNC), 267
Gram-positive cocci (GPC), and 16 Gram-positive bacilli (GPB) were tested. BMS and VMS correctly identified isolates to
genus and species levels (ID 97.3% and 93.2%, and 99.8% and 99.0%, respectively). Both systems as well as the CPS
correctly identified the majority of the species in the family Enterobacteriaceae, Pseudomonas spp., and Acinetobacter
baumannii. Turnaround time for identification by BMS and VMS was <20 min compared with 24-48 h by the CPS.
Conclusions: VMS performed slightly better than BMS with GPC ID, especially the Streptococcus spp. Some S. mitis
isolates were identified as S. pneumoniae by BMS. BMS and VMS were rapid and proved to be consistently accurate for
producing bacterial identification in a fraction of time it takes for identification by CPS.
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The routine identification of bacterial isolates in the hos-
pital clinical diagnostic microbiology laboratory is cur-
rently done by analysis of phenotypic characteristics such
as growth on selective and non-selective media, colonial
morphology, Gram-stain morphology and typical bio-
chemical reactions. These methods are laborious, time-
consuming and require a relatively long turn-around time.
Fast and cost-effective matrix-assisted laser desorption
ionization-time of flight mass spectrometry (MALDI-TOF
MS)-based systems have been developed essentially to re-
place the biochemical and other phenotypic systems for
routine identification of bacteria. This is because it is
now necessary to have a low-cost, fast and reproducible
method for bacterial identification in the routine diag-
nostic laboratory.
Initially, MALDI-TOF MS technique was developed
for industrial use to analyze and identify proteins.
However, two decades later, Holland et al., [1] and
Krishnamurthy and Ross [2] demonstrated that it could
be used for rapid identification of bacterial whole–cell
based on spectral pattern. But its potential for routine
use in microbial identification in clinical microbiology
laboratory was only demonstrated a few years ago [3-6].
This technique is based on the analysis of microbial pro-
teins by an ionization process devoid of fragmentation
by coordinated action of laser and small organic acids of
the matrix. These are then separated on the basis of
their mass-to-charge ratios, a process which results in a
characteristic mass spectral profile. Identification of
microbes is based on the comparison of the protein
spectrum generated from intact whole microbial cells to
a database of species-specific reference protein profiles.
Protein analysis by MALDI-TOF MS does not require
lengthy biochemical reactions, thereby making it a more
rapid identification strategy than traditional routine
methods [5,6].
Currently, commercial and user-friendly instruments
containing different algorithms for the identification of
microbial protein mass spectrum pattern along with a
database for thousands of reference bacteria are now avail-
able. These are Bruker Microflex MS (Bruker Daltonics,
Bremen, Germany), VITEK MS IBB (bioMerieux, Marcy
l’Etoile, France), VITEK MS RUO (formerly Saramis, bio-
Merieux) and Andromas system (Andromas SAS, Paris,
France) [7,8]. Many laboratories have focused on analysis
of specific bacterial genera using the MALDI-TOF MS
technology [9-14]. Other studies have analyzed general
groups of bacteria [15,16], and yeasts [17,18], or evaluated
its use in the routine clinical laboratory for bacterial iden-
tification [3-6,19,20].
In the current study, we carried out a comparative
evaluation of the performance of Bruker Microflex MS
(BMS, Daltonics) versus VITEK MS (VMS, bioMerieux)based on an updated classifier and database, in parallel
with routine phenotypic Vitek 2 system (CPS, bioMer-




Consecutive, clinically relevant, a broad diversity of bac-
terial isolates were tested during a period of six consecu-
tive months (January 2012 to June 2012) of routine
laboratory processing of clinical specimens in the Micro-
biology Laboratory, Mubarak Al Kabir hospital, Kuwait.
Duplicate isolates from the same patient were excluded.
The 806 isolates included in the study encompassed
Enterobacteriaceae, non-fermentative Gram-negative ba-
cilli, other Gram-negative bacteria, staphylococci and
related species, streptococci and related species, and
Gram-positive rods. They were isolated from different
sources- blood, urine, pus, tissue, wound, respiratory se-
cretion and body fluid. All identification tests were car-
ried out simultaneously by BMS, VMS and CPS as a part
of routine diagnostic workup.
Vitek 2 system
Routine bacterial identification in the laboratory was
carried out by Vitek 2 (bioMerieux). Gram-positive and
Gram-negative isolates were inoculated into GP ID (card
no. 21342) and GN ID (card no. 21341) respectively.
Neisseria and Haemophilus species were identified by
NH ID (card no. 21346). When necessary, complemen-
tary biochemical tests were done.
MALDI-TOF Bruker MS (BMS)
Measurements were done with a Microflex LT mass spec-
trometer (Bruker Daltonics) using FlexControl software
(version 3.3). The spectra were imported into the inte-
grated MALDI Biotyper software (version 3.0) and ana-
lyzed by standard pattern matching with a default setting.
The isolates were tested in duplicates directly and after
pretreatment. A colony from blood agar plate was directly
spotted on the MALDI plate, and then overlaid with 1 μl
of matrix solution and air-dried. The loaded plate was
then placed in the instrument according to the manufac-
turer’s instructions. The spectrum of each isolate was
compared with that in the database and the identification
was provided by a score of reliability (<1.7 = ID not reli-
able; ≥1.7 and <2.0 = ID at genus level; ≥2.0 = ID at species
level). A result was considered species consistent if all
matches with a log score ≥2.0 were of the same species
and if matches with a log score between 2.0 and 1.7 cor-
respond only to other species of the same genus. A genus
consistent result was accepted if all log scores ≥1.7 belong
to the same genus.
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The isolates were tested in duplicates directly on the
MALDI-plate. A single bacterial colony was deposited
on the target slide, followed by the addition of the
matrix (VITEK MS-CHCA) and air drying. The loaded
slide was inserted into the VITEK MS machine. VITEK
mass spectrometer was used to generate spectra of the
bacterial suspension and the Biotyper software (version
2.0) was used to analyze the results. Microbial identifica-
tion was achieved by obtaining the spectra using
MALDI-TOF technology and analyzing the spectra with
the VITEK MS database. The peaks from these spectra
were compared with the characteristic pattern for the
species, genus or family of the microorganism, leading
to identification of the organism. The results were evalu-
ated according to a colored index: green for ≥90% iden-
tity, yellow for 85–89.9% identity and white for <85%
identity. All of the identifications to the genus or species
level fell into the green zone, with a score of >90% con-
sidered reliable. Scores between 85 and 90% were con-
sidered as acceptable identification. A cut-off of 90% was
chosen for the VITEK MS.
Quality control
Escherichia coli ATCC 8739 was included as a positive
control and matrix alone with no organism was included
as a negative control in each run in both MALDI-TOF
systems.
Discrepancy
Discrepancies were defined as different genus- or species-
level identification obtained from the VITEK MS, Micro-
flex Bruker MS or conventional method Vitek 2. Whenever
there was a discrepancy, the analysis was repeated by
both systems to eliminate the possibility of contamination.
Thereafter, any other disagreements in the ID were re-
solved by performing 16S rRNA gene amplification and
sequencing on the discrepant isolates.
16S rRNA gene amplification
DNA from colonies obtained from samples with discord-
ant results emanating from the 3 identification systems
was extracted as previously described by Boom et al. [21].
The 16S rRNA genes were amplified and sequenced using
universal 16S rRNA-specific primers [22]. The sequences
obtained were compared with sequences present in the
GeneBank database using BLAST software (http://www.
ncbi.nih.gov).
Ethics statement
The evaluation of diagnostic systems was performed in
the routine Clinical Microbiology Laboratory whose job
is to provide support for patient care. Ethical approval isnot required for analysis of routine clinical specimens
sent to this laboratory.
Results
A total of 806 clinically significant pathogens comprising
507 Gram-negative bacilli (GNB), 16 Gram-negative cocci
(GNC), 267 Gram-positive cocci (GPC), and 16 Gram-
positive bacilli (GPB) made up of 39 genera and 70 species
were tested during the study period, as shown in Tables 1,
2, 3 and 4. Of the 806 isolates, conventional Vitek 2 sys-
tem correctly identified 795 (98.6%) to the genus level and
777 (96.4%) to the species level. VITEK MS identified 805
(99.9%) to the genus level and 798 (99.0%) to the species
level. Bruker Microflex MS identified 784 (97.3%) and 751
(93.2%) to the genus and species levels, respectively; 17
isolates were also correctly identified to the species level
but at no reliable ID score of <1.7. Both MALDI-TOF sys-
tems took less than 20 minutes from colony to ID result
compared with ≥24 h by CPS.
As shown in Table 1, bothVMS and Vitek 2 gave correct
and acceptable identification for 504/507 (99.4%) Gram-
negative bacilli. Using 16S rRNA sequencing results as the
gold standard, two Providencia rettgeri were misidentified
as Providencia stuartii and one Ralstonia solanacearum
was identified as Ralstonia pickettii. BMS gave correct and
an acceptable identification for 490/507 (96.6%) Gram-
negative bacilli. It could identify 11 Gram-negative bacilli
(1 Klebsiella pneumoniae, 3 Acinetobacter baumannii,
1 Acinetobacter lwoffii, 1 Salmonella species, 1 Stenotropho-
monas maltophilia, 1 P. rettgeri, 1 Burkholderia cepacia,
and 2 Sphingomonas paucimobilis) correctly but with an
unacceptable ID score of <1.7 when compared to sequen-
cing results. However, the system misidentified 4 Gram-
negative bacilli with an acceptable high ID score >2.0 (1 A.
baumannii as Acinetobacter genomospecies 13TU [this or-
ganism has been recently named as Acinetobacter nosoco-
mialis, http://www.bacterio.net/], 2 Aeromonas hydrophila/
caviae as Aeromonas jandaei, and 1 R. solanacearum as
Ralstonia insidiosa) compared to sequencing results. Both
systems correctly identified all Escherichia coli, Pseudo-
monas aeruginosa, Enterobacter spp., Proteus spp., Serratia
spp., Citrobacter spp. andMorganella spp.
As shown in Table 2, Vitek 2 gave correct and accept-
able identification for 255 (95.5%) of the 267 Gram-
positive cocci, while it could not identify Rhodococcus equi
as it is not present in its database. It misidentified 12
Gram-positive cocci: 1 Staphylococcus epidermidis mis-
identified as Staphylococcus capitis, 2 Micrococcus luteus/
lylae as Kocuria kristinae, 1 Streptococcus lutetiensis as
Streptococcus infantarius, 8 Streptococcus mitis/oralis
as Streptococcus constellatus; 3, Streptococcus peroris; 1,
Streptococcus pluranimalium; 1, Streptococcus pentosaceus;
1, Streptococcus sanguis; 1, Streptococcus thoraltensis; 1.
VMS correctly identified at an acceptable level, 263 (98.5%)
Table 1 Discrepancies and error in the conventional identification method (Vitek 2) and MALDI-TOF for the










16S rRNA sequence result
(number of discrepant
organisms sequenced)
No ID Mis-ID No ID Mis - ID No ID Mis-ID
Escherichia coli (181) 0 0 0 0 0 0
Klebsiella pneumoniae (71) 0 0 0 0 0 1 (score <1.7) K. pneumoniae (1)
Klebsiella oxytoca (2) 0 0 0 0 0 0
Pseudomonas
aeruginosa (66)
0 0 0 0 0 0
Acinetobacter
baumannii (39)




Acinetobacter lwoffii (2) 0 0 0 0 0 1 (score <1.7) A. lwoffii (1)
Salmonella spp. (29) 0 0 0 0 0 1 (score <1.7) Salmonella spp. (1)
Enterobacter cloacae (14) 0 0 0 0 0 0
Enterobacter
aerogenes (7)
0 0 0 0 0 0
Enterobacter asburiae (5) 0 0 0 0 0 0
Pantoea agglomerans (1) 0 0 0 0 0 0
Proteus mirabilis (17) 0 0 0 0 0 0
Stenotrophomonas
maltophilia (18)
0 0 0 0 0 1 (score <1.7) S. maltophilia (1)
Serratia marcescens (15) 0 0 0 0 0 0
Citrobacter koseri (9) 0 0 0 0 0 0
Citrobacter freundii (1) 0 0 0 0 0 0
Morganella morganii (7) 0 0 0 0 0 0
Achromobacter xylosoxidans (5) 0 0 0 0 0 2 (Acinetobacter spp.) A. xylosoxidans (2)
Providencia rettgeri (4) 0 2 (Providencia
stuartii)
0 2 (P. stuartii) 0 1 (score <1.7) P. rettgeri (2)
Burkholderia cepacia (2) 0 0 0 0 0 1 (score <1.7) B. cepacia (1)
Sphingomonas paucimobilis (2) 0 0 0 0 0 2 (score <1.7) S. paucimobilis (2)
Aeromonas hydrophila/
caviae (2)





0 1 (R. pickettii) 0 1 (Ralstonia insidiosa) R. solanacearum (1)
Chryseobacterium
indologenes (1)
0 0 0 0 0 0
Plesiomonas shigelloides (1) 0 0 0 0 0 0
Vibrio parahaemolyticus (1) 0 0 0 0 0 0
Campylobacter jejuni (1) 0 0 0 0 0 0
Bordetella pertussis (1) 0 0 0 0 0 0
Bordetella parapertussis (1) 0 0 0 0 0 0
Yersinia enterocolitica (1) 0 0 0 0 0 0
No ID = no identification in spite of its presence in database; Mis-ID =misidentification; *Current name is Acinetobacter nosocomialis.
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not present in its database but identified by 16S rRNA se-
quencing. VMS misidentified 5 Gram-positive cocci: 1 S.epidermidis as Staphylococcus capitis, 1 Staphylococcus
warneri as Staphylococcus auricularis, 1 Staphylococcus
lutetiensis as Staphylococcus infantarius, 1 S. mitis/oralis as
Table 2 Discrepancies and error in the conventional identification method (Vitek 2) and MALDI-TOF for the














No ID Mis-ID No ID Mis-ID No ID Mis-ID
Staphylococcus
aureus (53)
0 0 0 0 0 0
Staphylococcus
epidermidis (34)
0 1 (Staphylococcus capitis) 0 1 (S. capitis) 0 0 S. epidermidis (2)
Staphylococcus
haemolyticus (11)
0 0 0 0 0 0
S. capitis (11) 0 0 0 0 0 0
Staphylococcus
hominis (7)
0 0 0 0 0 0
Staphylococcus
lugdunensis (4)
0 0 0 0 0 0
Staphylococcus
caprae (1)
0 0 0 0 0 1 (Staphylococcus auricularis) S. caprae (1)
Staphylococcus
warneri (2)
0 0 0 S.auricularis 0 1 (S. epidermidis) S. warneri (1)
Streptococcus
agalactiae (46)
0 0 0 1 (Nocardia
asteroides)





0 0 0 0 0 0
Enterococcus
faecalis (29)
0 0 0 0 0 0
Enterococcus
faecium (6)
0 0 0 0 0 0
Enterococcus
raffinosus (3)
0 0 0 0 0 0
Enterococcus
avium (1)
0 0 0 0 0 0
Streptococcus
pyogenes (7)
0 0 0 0 0 0
Micrococcus luteus/
lylae (6)





NA NA NA NA 0 0 R. equi (1)
Streptococcus
parasanguis (3)
0 0 0 0 0 1 (Alloiococcus otitis) S. parasanguis (1)
Streptococcus
salivarius (1)
0 0 0 0 0 0
Streptococcus
lutetiensis (1)
0 1 (Streptococcus infantarius) 0 1 (Streptococcus
infantarius)
0 0 S. lutetiensis (1)
Streptococcus
dysagalactiae (2)
0 0 0 0 0 0
Streptococcus mitis/
oralis (26)






0 1 (S. constellatus) 0 18 (Streptococcus
pneumoniae)
S. mitis / oralis (26)
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Table 2 Discrepancies and error in the conventional identification method (Vitek 2) and MALDI-TOF for the
identification of 267 Gram-positive bacteria (Continued)
Streptococcus
anginosus (2)
0 0 0 0 0 0
Streptococcus
gallolyticus (1)
0 0 0 0 0 1 (Propionibacterium acnes) S. gallolyticus (1)
Granulicatella
adiacens (2)
0 2 (S. sanguinis, S. thoraltensis) 0 0 0 2 (S. pneumoniae,
Streptococcus oralis)
G. adiacens (2)
S. pneumoniae (5) 0 0 0 0 0 0
Streptococcus
mutans (1)
0 0 0 0 0 1 (P. acnes) S. mutans (1)
No ID = no identification in spite of its presence in database; Mis - ID =misidentification; NA = not present in database
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asteroides. Out of 267 Gram-positive cocci, BMS gave cor-
rect and acceptable identification for 237 (88.8%). It mis-
identified 30 Gram-positive cocci isolates. These were the
following: 1 Staphylococcus caprae as S. auricularis, 1
Staphylococcus warneri as S. epidermidis, 2 S. agalactiae as
Alloiococcus otitis and Lactobacillus sakei, 3 Micrococcus
luteus/lylae as Clostridium beijeriuckii 1; and Propionibac-
terium acnes 2; 1 Streptococcus parasanguis as Alloiococcus
otitis. Compared to sequencing results, 18 of 26 S. mitis/
oralis group were misidentified as Streptococcus pneumo-
niae. In addition, 1 S. gallolyticus was misidentified as
P. acnes and 1 Streptococcus mutans as P. acnes. All the 3
systems correctly identified all Staphylococcus aureus,
Streptococcus pyogenes, S. pneumoniae and Enterococcus
spp. to the genus and species levels.
Table 3 shows the discrepancies in the conventional
and MALDI-TOF methods (Vitek 2, BMS and VMS) for
identification of 16 Gram-negative cocci. Vitek 2 identi-
fied all Gram-negative cocci to the genus and species
levels except 5 Neisseria subflava for which database is
absent. VMS identified 15 (93.8%) of 16 Gram-negative
cocci correctly, and misidentified 1 Neisseria cinerea as
N. subflava, when compared to sequencing results.
However, BMS correctly identified only 8 (50%) of 16Table 3 Discrepancies and error in the conventional identifica
identification of 16 Gram-negative cocci
Final identification




No ID Mis - ID No ID Mis -
Haemophilus influenzae (8) 0 0 0 0
Neisseria cinerea (1) 0 0 0 1 (Ne
Neisseria subflava (5) NA NA 0 0
Neisseria meningitidis (1) 0 0 0 0
Moraxella catarrhalis (1) 0 0 0 0
No ID = no identification in spite of its presence in database; Mis - ID =misidentificaGram-negative cocci to the species and genus levels. It
correctly identified 2 of 8 Haemophilus influenzae, but
with an ID score of <1.7 and it misidentified 1N. cinerea
as Neisseria sicca and 5N. subflava as Neisseria flava,
when compared to sequencing results.
The discrepancies and errors among Vitek 2, BMS and
VMS for identification of 16 Gram-positive bacilli are
shown in Table 4. Vitek 2 correctly identified only 4 of
16 Gram-positive bacilli. Corynebacterium terpenotabi-
dum, Corynebacterium striatum, Lactobacillus jensenii
and Lactobacillus rhamnosus are not present in Vitek 2
data base. Compared to sequencing results, Vitek 2 mis-
identified 1 Nocardia otitidiscaviarum as Listeria mono-
cytogenes. VMS correctly identified to an acceptable
level, 14 (87.5%) of 16 Gram-positive bacilli. It misidenti-
fied 1 Corynebacterium terpenotabidum as Clostridium
septicum and 1N. otitidiscaviarum as L. monocytogenes.
BMS identified 13/16 (81.3%) Gram-positive bacilli, but
misidentified C. terpenotabidum as Clostridium beijerinckii,
1 Listeria ivanovii as L. monocytogenes and 1 N. otitidisca-
viarum as L. monocytogenes.
Discussion and conclusions
MALDI-TOF MS systems have been now implemented





16S rRNA sequence results
(number of discrepant
organisms sequenced)
ID No ID Mis - ID
0 2 (score <1.7) H. influenzae (2)
isseria subflava) 0 1 (Neisseria sicca) N. cinerea (1)
0 Neisseria flava (5) N. subflava (5)
0 0
0 0
tion; NA = not present in database.
Table 4 Discrepancies and error in the conventional identification method (Vitek 2) and MALDI-TOF for the
identification of 16 Gram-positive bacilli





VITEK MS identification Bruker MS identification 16S rRNA sequence results
(number of discrepant
organisms sequenced)
No ID Mis - ID No
ID










Lactobacillus jensenii (3) NA NA 0 0 0 0 L. jensenii (3)
Corynebacterium striatum (5) NA NA 0 0 0 0 C. striatum (5)
Lactobacillus rhamnosus (2) NA NA 0 0 0 0 L. rhamnosus (2)
Erysipelothrix rhusiopathiae (1) 0 0 0 0 0 0
Listeria monocytogenes (1) 0 0 0 0 0 0
Listeria ivanovi (2) 0 0 0 0 0 1 (L. monocytogenes) L. ivanovii (1)
Nocardia otitidiscaviarum (1) 0 1 (L. monocytogenes) 0 1 (L.
monocytogenes)
0 1 (L. monocytogenes) N. otitidiscaviarum (1)
No ID = no identification spite of its presence in database; Mis - ID =misidentification; NA = not present in database.
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tion of different bacterial isolates. This technology is
dependent on the reference strains included in their
databases. Thus, when an isolate is tested, the species of
the reference strain with the closest match is used for
identification of the tested strain.
An important advantage of MALDI-TOF system is rapid
identification of bacteria in just under 10 min compared
to CPS that takes 16–20 h. The commercial systems allow
the rapid identification of S. aureus but MALDI-TOF
can recognize different coagulase negative staphylococci
(CoNS). Identification of the exact species of CoNS may be
very useful because some CoNS can cause serious infec-
tions and it may help to differentiate contaminants from
true infections caused by CoNS [23]. A recent comparative
study by Dupont et al., [24] in which MALDI–TOF MS
and Vitek 2 were evaluated for the identification of 234
CoNS representing 20 different species showed that
MALDI-TOF MS significantly performed better than Vitek
2 (93.2% versus 75.2%) with fewer misidentifications. In
our study, all the 53 S. aureus isolates were correctly iden-
tified by MALDI-TOF MS and Vitek 2, while only 1 S.
epidermidis was misidentified by Vitek 2 and 2 isolates
each were misidentified by BMS and VMS.
S. pneumoniae is a major human pathogen and it has to
be identified reliably and accurately in the clinical micro-
biology laboratory. In our hands, the CPS and both
MALD-TOF systems identified it correctly which is dis-
cordant with the study of Seng et al. [5], which reported
that about 50% of S. pneumoniae isolates were misidenti-
fied as Streptococcus parasanguinis, a member of Strepto-
coccus mitis group. However, it should be pointed out that
in our study BMS and VMS misidentified 18 of 26 and 1
of 26 S. mitis/oralis group as S. pneumoniae, respectively,a finding that may clinically impact patient management.
Similar misidentification has been reported by others in
which MALDI-TOF MS system was found to misidentify
S. mitis/oralis as S. pneumoniae [6,25]. This misidentifica-
tion may be explained by the fact that S. pneumoniae is
strikingly similar to S. mitis genetically [26] and that the
resolving power of MALDI-TOF is not sufficient to dis-
criminate between the two species [18]. Therefore, supple-
mentary tests such as optochin disk susceptibility and bile
solubility are needed for the correct identification of S.
pneumoniae. It is important to subject an isolate to these
supplementary tests prior to reporting it as S. pneumoniae
because insertion of additional spectra of these species
into the BMS database may not solve the problem. In con-
trast to our findings, another study did not misidentify any
of the 369 non-pneumococcal streptococci and related
genera as S. pneumoniae [27]. Therefore, MALDI-TOF
MS analysis cannot be used alone for identification of
these organisms in all laboratories. It must be pointed out
that all enterococci isolates were correctly identified to the
species level by both MALDI-TOF MS systems which is
concordant with the report by van Veen et al., [6].
An important similarity in the performance of both
MALDI-TOF MS and Vitek 2 was their ability to correctly
identify Gram-negative bacteria, particularly the Entero-
bacteriaceae with few exceptions to genus and species
levels. Compared to the CPS identification of non-
fermenting Gram-negative bacilli which is frequently pro-
tracted, expensive and difficult, these rapid systems appear
to be superior. The explanation for the problems some-
times encountered with the CPS may be attributed to the
mucoid nature of some of these organisms or the fact that
they are inert biochemically [28]. Some previous studies re-
ported misidentification of S. maltophilia as Pseudomonas
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hibiscicola by BMS. This is thought to be related to a high
level of homology between the genera and the species
[5,6]. However, all our 18 S. maltophilia were correctly
identified by both BMS and VMS although 1 isolate which
was identified by BMS had a low ID score of <1.7.
In this study, the Corynebacterium species collected in
our routine practice were not identified by Vitek 2 pri-
marily because of a lack of database for this species.
Only 1 out of 6 isolates was misidentified as Clostridium
species by both BMS and VMS. This may be explained
by a lack of species diversity as previously alluded to by
Dubois et al. [27]. In the past, Gram-positive bacilli were
not routinely identified to species level as are Gram-
negative rods isolated from clinical specimens. The use
of MALDI-TOF MS in the clinical microbiology labora-
tory will provide species–level identification of these
bacteria. Conceivably, identification of Gram-positive ba-
cilli to species level may allow us to learn more about
the real clinical significance of these organisms and per-
haps help determine their hither - to underappreciated
pathogenic potential.
An important limitation of this study was the relatively
small number of Gram-negative cocci and Gram-
positive bacilli encountered during this study which
makes a general evaluation regarding their identification
rather weak. A prospective evaluation study involving a
large number of stock clinical isolates of these groups is
underway.
Several studies have also assessed the use of MALDI-
TOF MS to detect the mechanisms of antibiotic resistance
in Enterobacteriaceae, such as identification of β-lactams
and β-lactam modified/degraded products [29,30], de-
tection of resistance proteins within the cell [31,32] and
detection of mutations within resistance genes through
mini-sequencing [33]. In addition, MALDI-TOF MS has
been used in clinical practice to detect Enterobacteriaceae
producing extended spectrum β-lactamase from positive
blood cultures [34]. However, the limitation of these re-
ports is that these mechanisms will detect only one type of
resistance mechanism to certain antibiotics e.g. β-lactams,
which makes the clinical implication of their findings un-
sure at this time. Another notable limitation of the rapid
MALDI-TOF MS systems is that neither of them could
perform susceptibility testing for all antibiotics. In effect,
the physician still has to wait for another 24 h to make an
informed and definitive decision on appropriate antibiotic
therapy.
In conclusion, both MALDI-TOF MS systems have the
potential to replace the conventional methods for identifi-
cation of the majority of pathogens isolated in the clinical
microbiology laboratory. MALDI-TOF is a rapid, simple,
inexpensive, user-friendly and high-throughput proteomic
technique for identification of clinically significant bacteria(except viridans streptococci) which can be implemented
in a routine, conventional, laboratory setting.
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